Status
Conditions
Study type
Funder types
Identifiers
About
Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.
Full description
Investigators also investigate how genetic variants may affect cancer treatment, at various stages of disease development, in order to determine prognostic and predictive factors for survival.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Andrea Shafer, MPH; David Christiani, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal